A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was ...

“In Asia, people buy live birds at markets where they are plucked. The plucking has been shown to aerosolize virus from the ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX).

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it ...

The U.S. Senate Finance Committee on Tuesday voted in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the ...

A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of avian influenza ... and contracted Moderna to develop an mRNA-based 'pre-pandemic' flu vaccine ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...